<DOC>
	<DOCNO>NCT00414960</DOCNO>
	<brief_summary>To compare difference marker cellular proliferation bronchial biopsy specimen former smoker stratify lung cancer risk , collect treatment per patient enzastaurin placebo group .</brief_summary>
	<brief_title>A Trial Placebo Versus Enzastaurin Lung Cancer Prevention Former Smokers</brief_title>
	<detailed_description>x</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Sputum atypia participant normal sputum cytology remove study ) Metaplasia dysplasia least one bronchoscopy specimen History cigarette smoking &gt; 30 Pack Years Quit smoking &gt; 1 year prior study entry Able undergo bronchoscopy helical CT scan chest Able swallow tablet Blood clot abnormality Current smoking within past 1 year Unwillingness abstain smoke enrol clinical trial unwillingness avoid significant second hand smoke exposure Evidence lung cancer carcinoma situ Active cardiovascular disease Current illicit drug alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Healthy</keyword>
	<keyword>Prevention</keyword>
</DOC>